Medigen Biotechnology (3176) — Tangible Net Worth Ratio
Medigen Biotechnology (3176) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets (NT$0.00) from net assets (NT$4.90 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Medigen Biotechnology (3176) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Medigen Biotechnology Tangible Net Worth Ratio (2003–2024)
This chart shows how Medigen Biotechnology's Tangible Net Worth Ratio has changed across 22 annual periods from 2003 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of NT$4.90 Billion with intangible assets of NT$0.00 TWD. See 3176 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Medigen Biotechnology (2003–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Medigen Biotechnology from 2003 to 2024, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Medigen Biotechnology stock valuation.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | NT$5.04 Billion | NT$0.00 | NT$6.71 Billion | ▲ +0.6 pp |
| 2023 | 99.4% | NT$5.00 Billion | NT$30.36 Million | NT$8.53 Billion | ▼ 0.0 pp |
| 2022 | 99.4% | NT$6.47 Billion | NT$36.90 Million | NT$9.98 Billion | ▲ +0.2 pp |
| 2021 | 99.3% | NT$6.43 Billion | NT$48.08 Million | NT$8.20 Billion | ▲ +1.0 pp |
| 2020 | 98.2% | NT$4.50 Billion | NT$79.34 Million | NT$6.15 Billion | ▼ -1.8 pp |
| 2019 | 100.0% | NT$2.69 Billion | NT$0.00 | NT$4.83 Billion | ▲ +4.7 pp |
| 2018 | 95.3% | NT$2.94 Billion | NT$138.90 Million | NT$4.60 Billion | ▲ +1.7 pp |
| 2017 | 93.5% | NT$3.18 Billion | NT$205.26 Million | NT$4.87 Billion | ▲ +0.5 pp |
| 2016 | 93.0% | NT$3.54 Billion | NT$245.97 Million | NT$4.82 Billion | ▼ 0.0 pp |
| 2015 | 93.1% | NT$3.46 Billion | NT$239.84 Million | NT$4.49 Billion | ▲ +3.2 pp |
| 2014 | 89.9% | NT$3.66 Billion | NT$370.09 Million | NT$4.46 Billion | ▼ -4.5 pp |
| 2013 | 94.4% | NT$3.07 Billion | NT$172.25 Million | NT$3.29 Billion | ▲ +3.5 pp |
| 2012 | 90.9% | NT$2.05 Billion | NT$186.28 Million | NT$2.24 Billion | ▲ +7.6 pp |
| 2011 | 83.3% | NT$915.79 Million | NT$152.65 Million | NT$1.21 Billion | ▼ -1.7 pp |
| 2010 | 85.1% | NT$807.90 Million | NT$120.59 Million | NT$869.78 Million | ▲ +6.3 pp |
| 2009 | 78.7% | NT$597.02 Million | NT$126.87 Million | NT$679.27 Million | ▲ +4.0 pp |
| 2008 | 74.8% | NT$539.65 Million | NT$136.19 Million | NT$680.98 Million | ▼ -21.5 pp |
| 2007 | 96.2% | NT$468.68 Million | NT$17.69 Million | NT$593.03 Million | ▲ +37.7 pp |
| 2006 | 58.5% | NT$667.93 Million | NT$277.31 Million | NT$742.89 Million | ▲ +4.2 pp |
| 2005 | 54.2% | NT$650.39 Million | NT$297.55 Million | NT$702.17 Million | ▼ -0.3 pp |
| 2004 | 54.6% | NT$739.26 Million | NT$335.63 Million | NT$767.53 Million | ▲ +8.4 pp |
| 2003 | 46.2% | NT$856.65 Million | NT$460.87 Million | NT$966.81 Million | — |